108 related articles for article (PubMed ID: 38942756)
1. PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.
Acharya S; Ansari AH; Kumar Das P; Hirano S; Aich M; Rauthan R; Mahato S; Maddileti S; Sarkar S; Kumar M; Phutela R; Gulati S; Rahman A; Goel A; Afzal C; Paul D; Agrawal T; Pulimamidi VK; Jalali S; Nishimasu H; Mariappan I; Nureki O; Maiti S; Chakraborty D
Nat Commun; 2024 Jun; 15(1):5471. PubMed ID: 38942756
[TBL] [Abstract][Full Text] [Related]
2.
Acharya S; Mishra A; Paul D; Ansari AH; Azhar M; Kumar M; Rauthan R; Sharma N; Aich M; Sinha D; Sharma S; Jain S; Ray A; Jain S; Ramalingam S; Maiti S; Chakraborty D
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20959-20968. PubMed ID: 31570623
[TBL] [Abstract][Full Text] [Related]
3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
4. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
Mekler V; Kuznedelov K; Severinov K
J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
[TBL] [Abstract][Full Text] [Related]
6. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
Yang ZX; Fu YW; Zhao JJ; Zhang F; Li SA; Zhao M; Wen W; Zhang L; Cheng T; Zhang JP; Zhang XB
Genomics Proteomics Bioinformatics; 2023 Dec; 21(6):1206-1220. PubMed ID: 36549468
[TBL] [Abstract][Full Text] [Related]
7. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
Wang GH; Wang CM; Wu XJ; Chu T; Huang DW; Li J
Mol Biol (Mosk); 2024; 58(1):157-159. PubMed ID: 38943587
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.
Kang M; Zuo Z; Yin Z; Gu J
J Chem Inf Model; 2022 Jun; 62(12):3057-3066. PubMed ID: 35666156
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
10. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
Casini A; Olivieri M; Petris G; Montagna C; Reginato G; Maule G; Lorenzin F; Prandi D; Romanel A; Demichelis F; Inga A; Cereseto A
Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739
[TBL] [Abstract][Full Text] [Related]
11. Structure and Engineering of Francisella novicida Cas9.
Hirano H; Gootenberg JS; Horii T; Abudayyeh OO; Kimura M; Hsu PD; Nakane T; Ishitani R; Hatada I; Zhang F; Nishimasu H; Nureki O
Cell; 2016 Feb; 164(5):950-61. PubMed ID: 26875867
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
[TBL] [Abstract][Full Text] [Related]
13. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
14. Precise and broad scope genome editing based on high-specificity Cas9 nickases.
Wang Q; Liu J; Janssen JM; Le Bouteiller M; Frock RL; Gonçalves MAFV
Nucleic Acids Res; 2021 Jan; 49(2):1173-1198. PubMed ID: 33398349
[TBL] [Abstract][Full Text] [Related]
15. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
Kim D; Luk K; Wolfe SA; Kim JS
Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
[TBL] [Abstract][Full Text] [Related]
16. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
[TBL] [Abstract][Full Text] [Related]
17. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity.
Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z
Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321
[TBL] [Abstract][Full Text] [Related]
18. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
19. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
20. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
